At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

New guidelines for diabetes treatment, mpox research, and healthcare system improvements discussed in comprehensive health ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

KARACHI: Diabetes has led to a surge in severe health complications in Pakistan with nearly three million patients suffering ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...